AllDocs -> cancers

Kidney Cancer Association endorses American Medical Association position on drug importation Expresses concern about the authenticity of imported medicines (PRWEB) December 10, 2004 -- The Kidney Cancer Association (KCA) endorses the American Medical Association's (AMA) vote this week to support the importation of prescription drugs by wholesalers and pharmacies when certain conditions are met to ensure patient safety. In addition, the KCA is pleased with the AMA's vote to place patient safety issues at a high and visible level of importance. The KCA shares concerns over, as stated in the AMA report, of the “authenticity and quality of prescription drugs, already available in the U.S., that have been purchased by U.S. citizens in Mexico and from other foreignsites." The AMA also raised concerns about Canadian Internet pharmacies being recommended by the states of Minnesota and Wisconsin, stating ...

CL1 Human, kidney cancer Age Sex Diagnosis Size(cm) Capsule Vein Other N M 1 52 F RCC, granular cell types 12 + - - NX M0 2 60 F RCC, clear cell type 6 + + - N0 M1 3 42 M RCC, clear cell type 9 + + - NX M0 4 59 M RCC, clear cell type 7.5 + - - NX M0 5 67 F RCC, clear cell and granular cell type 8 + - - NX M0 6 65 M RCC, granular and clear cell type 11 + - - NX M0 7 59 M RCC, clear cell and granular cell type 7 + + - NX M0 8 56 M RCC, clear and pseudosarcomatous type 7 + - - NX M1* 9 42 F RCC, clear cell type ...

Annual incidence of cancer per 100,000 circa 1993-97 by region of the world (age-standardized to World Population) Cancer site : Kidney Males Incidence (95% confidence limits) 14.17 (13.97, 14.38) 13.02 (11.90, 14.13) 12.06 (11.47, 12.66) 11.14 (10.97, 11.30) 10.45 (10.24, 10.67) 10.30 (9.38, 11.23) 10.25 (10.10, 10.40) 9.99 (9.73, 10.26) 9.22 (8.64, 9.80) 7.86 (7.73, 7.98) 6.32 (6.11, 6.53) 5.24 (4.69, 5.79) 4.99 (4.67, 5.30) 4.20 (4.12, 4.27) 3.59 (3.46, 3.72) 3.55 (3.18, 3.92) 2.70 (1.96, 3.41) 5.95 (5.61, 6.29) 1.95 (1.21, 2.70) 1.81 (1.34, 2.27) 1.70 ...

KIDNEY CANCER (ADULT) - RENAL CELL CARCINOMA - All Sections KIDNEY CANCER (ADULT) - RENAL CELL CARCINOMA What Is Cancer ? Cancer develops when cells in a part of the body begin to grow out of control. Although there are many kinds of cancer , they all start because of out-of-control growth of abnormal cells. Normal body cells grow, divide, and die in an orderly fashion. During the early years of a person's life, normal cells divide more rapidly until the person becomes an adult. After that, cells in most parts of the body divide only to replace worn-out or dying cells and to repair injuries. Because cancer cells continue to grow and divide, they are different from normal cells. Instead of dying, they outlive normal cells and continue to form new abnormal cells. Cancer cells develop because of damage to DNA. This substance is in every cell and directs all its activities. ...

July 28, 2004 Vaccine shows progress for breast and kidney cancer Reuters Health: http://www.reutershealth.com/ NEW YORK (Reuters Health) - In an early-stage clinical trial, two women with metastatic breast cancer experienced significant tumor regression after being treated with an experimental cancer vaccine. Another woman with metastatic breast cancer and five kidney cancer patients had their disease stabilize following vaccination. The so-called "fusion cell vaccine" is prepared by fusing whole tumor cells taken from the patient, with dendritic cells (DCs), Boston-based researchers led by Dr. David Avigan from Beth Israel Deaconess Medical Center report in Clinical Cancer Research. With most DC-based vaccines, DCs are combined with a specific tumor protein, or antigen, that elicits an immune response, an approach that has been met with "some success in early trials," Avigan ...

June 8, 2004 Merix Bioscience Launches Trial for New Kidney Cancer Vaccine Merix Bioscience, Inc. : gibbs-soell.com Durham, N.C. – June 8, 2004 – Durham-based Merix Bioscience, a company pioneering therapeutic cancer vaccines, announced its first corporate-sponsored clinical trial, a trial with potential significant impact on the future treatment of kidney (renal) cancer . The trial for an RNA-loaded autologous dendritic cell vaccine is now in Phase I/II study at five clinical sites in the United States and Canada. “We have developed a cancer vaccine that harnesses the ability of an individual’s immune system to fight disease,” said Clint G. (Skip) Dederick, Jr., chairman, president and CEO of Merix. “We strongly believe that by utilizing an individual patient’s tumor antigens to create a personalized vaccine, we can induce the broadest possible immune response and maximize the anti-tumor responses.” ...

Annual cancer incidence and death rates per 100,000 South Australians by age, 1991-2001 Cancer site: Kidney Males 0.0 25.0 50.0 75.0 100.0 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80* Age (yrs.) R a te/ 100, 000 Incidence Mortality Females 0.0 25.0 50.0 75.0 100.0 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80* Age (yrs.) R a te/ 1 00, 000 Incidence Mortality Both 0.0 10.0 20.0 30.0 40.0 50.0 60.0 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80* Age (yrs.) R a te/ 100, 000 Incidence Mortality

kidney cancer Experimental Kidney Cancer Therapy That has Shown Promise in Small Study is Being Evaluated at UC San Diego By Troy Brown, R.N. Encouraged by dramatic results from a National Institutes of Health (NIH) study of patients with advanced kidney cancer who received an investigational type of stem-cell transplant, researchers at the University of California, San Diego (UCSD) Blood and Marrow Transplant Program are now evaluating the procedure in a new clinical study. Advanced kidney cancer is a devastating disease, leaving less than 10 percent of patients alive for more than five years after diagnosis, and killing many within the first year. Until now, these patients have had relatively few treatment options in the face of a rapidly progressing disease. This began to change, however, after a study sponsored by the National ...

74 17 Cancer of the kidney Summary During 1992–1997, one-year relative survival after diagnosis of cancer of the kidney was 77.2% for males and 73.5% for females, and five-year relative survival was 59.9% for males and 57.5% for females (Table 17.1). Relative survival ten years after diagnosis was 47.7% for males and 46.2% for females in 1987–1991, the most recent period for which ten-year relative survival data are available (Figure 17.2; Tables 17.2 and 17.3). Between 1982–1986 and 1992–1997, kidney cancer relative survival increased significantly. Five-year relative survival increased from 50.8% to 59.9% for males and increased from 49.4% to 57.5%for females. There was no significant change one year after diagnosis for males whereas for females, relative survival after one year increased from 67.4% to 73.5% (Figure 17.2; Tables 17.2 and 17.3). As age at diagnosis increased, ...

Kidney cancer The kidneys are part of the urinary system. The human body has two kidneys, one on either side of the middle of the back, just under the ribs. The kidneys: • Remove waste products from the blood. • Produce hormones which regulate blood pressure, control the body's calcium levels, and trigger the production of red blood cells in bones. Around 85 per cent of kidney cancers are renal cell carcinomas. Cancer cells initially grow in the lining of one or both kidneys. Without treatment, the cancer may spread to other areas of the body. Kidney cancer is more common in people over the age of 55 years. It is more common in men than women. About 520 Victorians are diagnosed with kidney cancer every year. Symptoms In its early stages, kidney cancer may have no symptoms. The disease may be discovered ...

Kidney Cancer The National Cancer Institute ( http://www. cancer .gov/ ), lists kidney cancer as one of 13 common causes of cancer and provides the following information. To obtain a free copy of this document, go to www.masterdocs.com . Understanding Cancer Cancer begins in cells, the building blocks that make up tissues . Tissues make up the organs of the body. Normally, cells grow and divide to form new cells as the body needs them. When cells grow old, they die, and new cells take their place. Sometimes this orderly process goes wrong. New cells form when the body does not need them, and old cells do not die when they should. These extra cells can form a mass of tissue called a growth or tumor . Not all tumors are cancer . Tumors can be benign or malignant : Benign tumors are not cancer : • Benign tumors are rarely life-threatening. ...

Nephrectomy (Removal of the Kidney ) Kidney cancer is a common malignancy with over 30,000 patients afflicted in the United States per year. The incidence of kidney cancer is increasing which is partially due to the increased use of cross-sectional imaging such as CT and MRI. At the UCSF Comprehensive Cancer Center, we provide state-of -the-art care to the entire spectrum of patients with renal cancer , from those with suspicious x-rays without a diagnosis to the care of patients with advanced or recurrent kidney cancer . Surgical removal of the cancer is the most effective form of treatment for patients whose cancer is confined to the kidney . Traditionally this has been through a procedure called radical nephrectomy. Radical nephrectomy is an open surgical procedure performed through an abdominal or flank incision during which the kidney , the fat surrounding the kidney ...

Table 1.22a - Major ablative procedures associated with cancer of the kidney (ICD-9 189.0, 189.8, 189.9) in British Columbia 1999/2000 8 17 25 - - 7 15 0 25 7.6% 9.8% 9.0% - - 8.3% 9.9% .0% 9.0% 32.0% 68.0% 100.0% - - 28.0% 60.0% .0% 100.0% 97 155 252 8 11 75 136 22 252 92.4% 89.1% 90.3% 88.9% 84.6% 89.3% 90.1% 100.0% 90.3% 38.5% 61.5% 100.0% 3.2% 4.4% 29.8% 54.0% 8.7% 100.0% 0 - - 0 0 - 0 0 - .0% - - .0% .0% - .0% .0% - .0% - - .0% .0% - .0% .0% - 0 - - 0 0 - 0 0 - .0% - - .0% .0% - .0% ...

A214: Kidney and ureter cancer tissues For research use only (formalin fixed) Specifications: • No. of cases: 31 • Tissue type: Kidney and ureter cancer tissues ( kidney :28, ureter:3) • No. of spots: 2 spots from each cancer case (62 spots) 6 non-neoplastic spots (6 spots) • Total spots: 68 • Corresponding normal tissues with cancers: Yes • Diameter: 1. 0 mm Documents : • Product specification: layout, summary of tissue spots • H&E stained images • Detailed pathological information Layout: Page 2 A214: Kidney and ureter cancer tissues For research use only (formalin fixed) Summary of tissue spots No. Sex Age Key Word Grade TNM Stage 1 1,2 M 45 RCC.conventional type 1 T1aN0M0 (I) ...

kidney cancer ¨ MASH Athletics ¨ LIFT FOR LIFE ¨ To Benefit The Kidney Cancer Association ¨ October 6, 2004 To whom it may concern, Mechanicsburg Area Senior High School is sponsoring a Lift for Life competition on March 5, 2005 to raise funds for the Kidney Cancer Association. We are requesting your help in the form of prize donations or monetary contributions that will be used for the purchase of prizes, tee shirts, or funds for the Association. Gifts and/or donations of $50 will result in the sponsor?s name or organization being listed on the tee shirts. Contributions of $100 or more will result in the printing of the sponsor?s logo on the tee-shirts. All sponsors and donors will also be listed in the program. All business donors/sponsors will also ...

Abstract. An allogeneic irradiated RCC cell line, engi- neered to produce IL-2 (ACHN-IL-2), admixed with autologous metastatic formalin-treated tumour cells, was used to vaccinate ten MRCC patients in progres- sion of disease in spite of IL-2 immunotherapy. The cells were administered subcutaneously and/or intra- tumourally. Sixty-four MRCC patients in progressive disease, not treated by vaccination but receiving simi- lar IL-2 immunotherapy, were considered as the con- trol group. Patients received 4ñ16 injections (mean 9 ± 4), contain- ing an average of 10.6 x 10 7 ± 7.7 x 10 7 ACHN-IL-2- transfected cells (a minimum of 4 x 10 7 , and a maximum of 31 x 10 7 ). Four patients also received intra-tumour injections. Vaccination was administered during 30ñ418 days, and the follow-up ...

Cancer in Northern Ireland 1993 - 2001: A Comprehensive Report 105 18: Cancer of the Kidney (C64-C66, C68) Incidence In 2001, cancer of the kidney was the tenth most common cancer in males and the thirteenth commonest in females. On average, 99 males and 65 females were diagnosed as having cancer of the kidney each year, accounting for about 2% of male and 1% of female cancers. Age Given the levels of disease in 2001, the risk of getting cancer of the kidney before the age of 75 years was 1 in 85 for males and 1 in 172 for females (Table 18a). Fifty percent of males were diagnosed under the age of 67 years, whilst for females it was 68 years. The average annual incidence for cancer of the kidney rose in males and females up to 70-74 years, with the age- specific rates consistently higher in males (Figure 18a). Prevalence In Northern Ireland on ...

kidney cancer Stem Cell Transplants for Patients with Kidney Cancer Study: New England Journal of Medicine Date: Sept 2002 Patients with renal cell carcinoma, a form of kidney cancer , may have a new treatment option. Preliminary results of several small studies suggest that moderate dosages of chemotherapy, followed by a blood stem cell transplant, may shrink tumors in patients with metastatic ( cancer that has spread to other parts of the body) renal cell carcinoma. Researchers at the National Heart, Lung and Blood Institute (NHLBI), who pioneered this treatment and have the largest experience to date, first reported their findings in September, 2000 in the New England Journal of Medicine. Nine of 19 patients who had an advanced form of renal cell carcinoma, and who had failed conventional therapies, were alive 287 to 831 days after treatment. The patients had received moderate ...

removal of a perirenal fibrolipoma. Partial nephrecto- my to treat renal malignancy was first described in 1890 by Czerny. 2 In 1950,Vermooten 3 reported that peripherally located, encapsulated renal tumors could be removed by partial excision of renal tissue. Partial nephrectomy has now become a standard procedure for appropriately selected patients with renal cell car- cinoma (RCC). Indications Nephron-sparing surgery is indicated for cases in which a radical nephrectomy would render the patient anephric with a subsequent immediate need for dialy- Current Status of Partial Nephrectomy in the Management of Kidney Cancer Arndt van Ophoven, MD, Ke-Hung Tsui, MD, Oleg Shvarts, Sherelle Laifer-Narin, MD, and Arie S.Belldegrun, MD Background: The technique of partial nephrectomy for managing renal cancers is well recognized, but ...

Web Immagini Gruppi Directory News Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:kYFZsPY7f9cJ:www.kidneycancerassociation.org/PDF%20Library/KCA%20Guidelines%20for%20Patient%20Meetings%2009-10-04.pdf allintitle: kidney cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: - Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero ...

Dietary acrylamide and cancer of the large bowel, kidney , and bladder: Absence of an association in a population-based study in Sweden LA Mucci* ,1,2 , PW Dickman 1,3 , G Steineck 3 , H-O Adami 1,2 and K Augustsson 1 1 Department of Medical Epidemiology, Karolinska Institutet, Box 281, SE 171 77 Stockholm, Sweden; 2 Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, 9th floor, Boston, MA 02115, USA; 3 Department of Oncology and Pathology, Clinical Cancer Epidemiology, Karolinska Institutet, SE 171 76 Stockholm, Sweden Recently, disturbingly high levels of acrylamide were unexpectedly detected in widely consumed food items, notably French fries, potato crisps, and bread. Much international public concern arose since acrylamide has been ...

Condition Prostate cancer Fungus Cirrhosis of the liver Bacteria Colorectal cancer Kidney disease Unknown Control Acid/Alkaline/Both Acid Acid Both (acidic & 10) Alkaline (8 & 10) Alkaline (10) Alkaline (10) Inhibited at 65 degrees Partially (10m at 65) No Alkaline (20min at 65) Not after 1hr at 65 Not after 1hr at 65 Not after 1hr at 65 MgCl2 required No No No Yes Yes Yes ZnCl2 required No No Yes, alkaline Yes Yes Yes EDTA Inhibited No No No Yes Yes Yes Tartrate Inhibited Yes No Yes, partially (acid) No Levamisole inhibited Yes, alkaline Yes No Yes NaF No No Disease

Kidney Cancer (Renal Cancer ) What are the kidneys? The two kidneys lie to the sides of the upper abdomen (the loins), behind the intestines, and either side of the spine. Each kidney is about the size of a large orange, but bean-shaped. A large renal artery takes blood to each kidney . The artery divides into many tiny blood vessels (capillaries) throughout the kidney . Tiny structures in the kidneys called nephrons 'filter' the blood contained in the capillaries. Water and waste materials which filter through the walls of the capillaries into the nephrons form urine. Urine passes along thin channels (tubules) which are part of each nephron, into larger channels (ducts) which drain the urine into the renal pelvis (the inner part of the kidney ). Urine passes down a tube called a ureter which goes from each kidney to the bladder. Urine ...

CXCR4/CXCL12 expression and signalling in kidney cancer AJ Schrader 1,2 , O Lechner 1 , M Templin 1 , KEJ Dittmar 1 , S Machtens 3 , M Mengel 4 , M Probst-Kepper 1 , A Franzke 5 , T Wollensak 2 , P Gatzlaff 1 , J Atzpodien 5 , J Buer* ,1,6 and J Lauber 1 1 Department of Cell Biology and Immunology, German Research Centre for Biotechnology (GBF), D-38124 Braunschweig, Germany; 2 Department of Visceral Surgery and Urology, Klinikum Braunschweig, D-38126 Braunschweig, Germany; 3 Department of Urology, Medizinische Hochschule Hannover (MHH), D-30623 Hannover, Germany; 4 Department of Pathology, Medizinische Hochschule Hannover (MHH), D-30623 Hannover, Germany; ...

Kidney Cancer Patient and Family Information and Support Program WHERE: Room 3052 in the Anschutz Cancer Pavilion 1635 N. Ursula St. Aurora, CO 80045 WHEN: 6:00p.m. to 7:30p.m. 2 nd Thursday of Every Month WHO: Patients, Family Members & Caregivers DATE: TOPIC: 1/13/2005 January Nutrition and Kidney Cancer [Colleen Gill, MS, RD] 2/10/2005 February Palliative Care [Jean Kutner, MD and Harri Brackett, RN, BSN, OCN] 3/10/2005 March Radiation therapy and Kidney Cancer [Brian Kavanagh, MD, MPH] 4/14/2005 April Clinical updates on Kidney Cancer [Harry Drabkin, MD] 5/12/2005 May Clinical Trials and Kidney Cancer [Bruno Medeiros, MD] 6/9/2005 June Pain Management ...

All-Ireland cancer statistics 1994-96 88 Kidney , except renal pelvis 19. MALIGNANT CANCER OF THE KIDNEY , EXCEPT RENAL PELVIS (summary) ICD-O.2 C64 ICD-10 C64 ICD-9 189.0 Figures presented here relate to kidney only, but comparison with EU figures is based on kidney in combination with renal pelvis (ICD-10 C65), ureter (C66), and urethra, paraurethral gland and unspecified urinary organs (C68). Key facts • Average of 341 new cases per year, 1994-96: 135 in females, 206 in males. • Average of 181 deaths per year: 68 in females, 113 in males. • Age-standardised incidence and mortality rates about twice as high in males as in females • 10th most common site for cancer incidence in males, 16th in females. • 10th most common cause of cancer deaths in males, 13th in females. • All-Ireland incidence rates ...